TEVA - Teva Pharmaceutical Industries Limited

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 513.16B
Enterprise value 339.67B
Trailing P/E N/A
Forward P/E 14.75
PEG Ratio (5 yr expected) 11.47
Price/sales (ttm)0.77
Price/book (mrq)1.00
Enterprise value/revenue 32.32
Enterprise value/EBITDA 68.46

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 362.07%
S&P500 52-week change 37.73%
52-week high 313.76
52-week low 36.07
50-day moving average 312.23
200-day moving average 310.83

Share statistics

Avg vol (3-month) 310.81M
Avg vol (10-day) 38.1M
Shares outstanding 51.1B
Float 1.09B
% held by insiders 10.60%
% held by institutions 154.67%
Shares short (29 Jun 2020) 421.87M
Short ratio (29 Jun 2020) 42.4
Short % of float (29 Jun 2020) 4N/A
Short % of shares outstanding (29 Jun 2020) 42.00%
Shares short (prior month 28 May 2020) 417.54M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 Dec 2017
Ex-dividend date 426 Nov 2017
Last split factor 22:1
Last split date 330 Jun 2004

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Mar 2020

Profitability

Profit margin -4.83%
Operating margin (ttm)17.61%

Management effectiveness

Return on assets (ttm)3.27%
Return on equity (ttm)-5.78%

Income statement

Revenue (ttm)17.1B
Revenue per share (ttm)15.66
Quarterly revenue growth (yoy)5.00%
Gross profit (ttm)7.54B
EBITDA 4.69B
Net income avi to common (ttm)-825M
Diluted EPS (ttm)-0.76
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.8B
Total cash per share (mrq)1.65
Total debt (mrq)26.51B
Total debt/equity (mrq)181.75
Current ratio (mrq)1.05
Book value per share (mrq)12.35

Cash flow statement

Operating cash flow (ttm)941M
Levered free cash flow (ttm)2.54B